COMP <GO>
CODX vs ICCM // REVENUE GROWTH (YOY)
Co-Diagnostics Inc. (NASDAQ) VS. IceCure Medical Ltd. (NASDAQ) • 15-METRIC TALLY: CODX 3
— ICCM 2
▲ REVENUE GROWTH (YOY) LEADER: ICCM
LAST: $0.40 (-10.49%) • MKT CAP: $3.5M
revenue-growth
-65.00%
LAST: $0.96 (-2.13%) • MKT CAP: $3.3M
revenue-growth
2.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CODX VS. ICCM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CODX | ICCM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.30% | 36.30% | +28.00 | CODX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -65.00% | 2.70% | -67.70 | ICCM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | ICCM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 19.1 | 18.1 | +1.00 | CODX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.5M | $3.3M | $206.9K | CODX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CODX REV | ICCM REV | CODX GROSS % | ICCM GROSS % | CODX FCF | ICCM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $622.5K | $3.4M | 64.3% | 36.3% | -$29.8M | -$14.6M |
| FY 2024 | $3.9M | $3.3M | 74.5% | 44.1% | -$29.9M | -$12.6M |
| FY 2023 | $6.8M | $3.2M | — | — | -$22.1M | -$12.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CODX // BETA —
ICCM // BETA —